Lung transplantation for systemic sclerosis and other connective tissue diseases

Rajan Saggar (Los Angeles, United States of America)

Source: International Congress 2017 – Difficult indications for lung transplantation
Session: Difficult indications for lung transplantation
Session type: Symposium
Number: 1442

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rajan Saggar (Los Angeles, United States of America). Lung transplantation for systemic sclerosis and other connective tissue diseases. International Congress 2017 – Difficult indications for lung transplantation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systemic and connective tissue diseases
Source: Eur Respir Monogr 2018; 81: 254-266
Year: 2018


Pulmonary involvement in Moldova lupus study
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013

Undifferentiated connective tissue disease at risk for systemic sclerosis: is heart function already impaired?
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017


HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Pulmonary arterial hypertension in connective tissue diseases
Source: Eur Respir Mon 2012; 57: 42-57
Year: 2012


Respiratory function in systemic sclerosis patients
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015


IL-17+ cells immunoexpression in systemic sclerosis pulmonary fibrosis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Features of pulmonary involvement in patients with diffuse connective tissue diseases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011


Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011


Occult connective tissue diseases mimicking idiopathic interstitial pneumonias
Source: Eur Respir J 2008; 31: 11-20
Year: 2008



Clinico-radiological profile of connective tissue diseases related interstitial lung diseases
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Lung structure and function relation in systemic sclerosis: Application of lung densitometry
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015

Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27
Year: 2005

Interstitial lung disease in the connective tisssue disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy},
Source: Eur Respir J 2012; 40: 641-648
Year: 2012



Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016